GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (NSE:TATVA) » Definitions » PE Ratio (TTM)

Tatva Chintan Pharma Chem (NSE:TATVA) PE Ratio (TTM) : 117.40 (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-15), Tatva Chintan Pharma Chem's share price is ₹886.40. Tatva Chintan Pharma Chem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹7.55. Therefore, Tatva Chintan Pharma Chem's PE Ratio (TTM) for today is 117.40.


The historical rank and industry rank for Tatva Chintan Pharma Chem's PE Ratio (TTM) or its related term are showing as below:

NSE:TATVA' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 46.98   Med: 79.48   Max: 133.77
Current: 116.34


During the past 6 years, the highest PE Ratio (TTM) of Tatva Chintan Pharma Chem was 133.77. The lowest was 46.98. And the median was 79.48.


NSE:TATVA's PE Ratio (TTM) is ranked worse than
91.48% of 1138 companies
in the Chemicals industry
Industry Median: 24.82 vs NSE:TATVA: 116.34

Tatva Chintan Pharma Chem's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was ₹-0.29. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹7.55.

As of today (2024-12-15), Tatva Chintan Pharma Chem's share price is ₹886.40. Tatva Chintan Pharma Chem's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was ₹7.58. Therefore, Tatva Chintan Pharma Chem's PE Ratio without NRI for today is 116.94.

During the past 6 years, Tatva Chintan Pharma Chem's highest PE Ratio without NRI was 133.25. The lowest was 46.98. And the median was 75.73.

Tatva Chintan Pharma Chem's EPS without NRI for the three months ended in Sep. 2024 was ₹-0.29. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was ₹7.58.

During the past 12 months, Tatva Chintan Pharma Chem's average EPS without NRI Growth Rate was -65.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -17.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 7.40% per year.

During the past 6 years, Tatva Chintan Pharma Chem's highest 3-Year average EPS without NRI Growth Rate was 65.00% per year. The lowest was -17.40% per year. And the median was 4.80% per year.

Tatva Chintan Pharma Chem's EPS (Basic) for the three months ended in Sep. 2024 was ₹-0.29. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹7.55.


Tatva Chintan Pharma Chem PE Ratio (TTM) Historical Data

The historical data trend for Tatva Chintan Pharma Chem's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem PE Ratio (TTM) Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PE Ratio (TTM)
Get a 7-Day Free Trial N/A N/A 51.75 81.23 81.41

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.81 95.09 81.41 98.15 139.26

Competitive Comparison of Tatva Chintan Pharma Chem's PE Ratio (TTM)

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem's PE Ratio (TTM) Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's PE Ratio (TTM) falls into.



Tatva Chintan Pharma Chem PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Tatva Chintan Pharma Chem's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=886.40/7.550
=117.40

Tatva Chintan Pharma Chem's Share Price of today is ₹886.40.
Tatva Chintan Pharma Chem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7.55.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Tatva Chintan Pharma Chem  (NSE:TATVA) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Tatva Chintan Pharma Chem PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem Headlines

No Headlines